A carregar...

Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical Trials

Duchenne muscular dystrophy (DMD) is an X-linked human disorder in which absence of the protein dystrophin causes degeneration of skeletal and cardiac muscle. For the sake of treatment development, over and above definitive genetic and cell-based therapies, there is considerable interest in drugs th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kornegay, Joe N., Spurney, Christopher F., Nghiem, Peter P., Brinkmeyer-Langford, Candice L., Hoffman, Eric P., Nagaraju, Kanneboyina
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4158345/
https://ncbi.nlm.nih.gov/pubmed/24936034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ilar/ilu011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!